首页> 美国卫生研究院文献>Clinical and Translational Science >The Translational Science Benefits Model: A New Framework for Assessing the Health and Societal Benefits of Clinical and Translational Sciences
【2h】

The Translational Science Benefits Model: A New Framework for Assessing the Health and Societal Benefits of Clinical and Translational Sciences

机译:转化科学利益模型:评估临床和转化科学对健康和社会利益的新框架

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We report the development of the Translational Science Benefits Model (TSBM), a framework designed to support institutional assessment of clinical and translational research outcomes to measure clinical and community health impacts beyond bibliometric measures. The TSBM includes 30 specific and potentially measurable indicators that reflect benefits that accrue from clinical and translational science research such as products, system characteristics, or activities. Development of the TSBM was based on literature review, a modified Delphi method, and in‐house expert panel feedback. Three case studies illustrate the feasibility and face validity of the TSBM for identification of clinical and community health impacts that result from translational science activities. Future plans for the TSBM include further pilot testing and a resource library that will be freely available for evaluators, translational scientists, and academic institutions who wish to implement the TSBM framework in their own evaluation efforts.
机译:我们报告了转化科学效益模型(TSBM)的发展,该模型旨在支持对临床和转化研究结果进行机构评估,以衡量除文献计量学方法外的临床和社区健康影响。 TSBM包含30项具体且可能可测量的指标,这些指标反映了临床和转化科学研究所产生的收益,例如产品,系统特性或活动。 TSBM的开发基于文献综述,改进的Delphi方法以及内部专家小组的反馈。三个案例研究说明了TSBM识别转化科学活动对临床和社区健康的影响的可行性和面部有效性。 TSBM的未来计划包括进一步的试点测试和资源库,这些库将免费提供给希望在自己的评估工作中实施TSBM框架的评估人员,翻译科学家和学术机构。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号